单孔机器人辅助胸腔镜手术的前瞻性真实世界研究
该研究在中国人群中评估达芬奇单孔手术系统用于解剖性肺切除的有效性与安全性,15例高度恶性肺结节患者手术均成功,无中转开腹,3例因高BMI和解剖复杂加辅助孔。中位术中出血15mL、手术时间100分钟、住院8天、胸管留置2天,无再住院。单孔机器人组手术时间更短、出血更少。
要点
- 达芬奇单孔机器人胸腔镜解剖性肺切除安全可行,15例均成功无中转。
- 中位术中出血15mL、手术时间100分钟,住院8天、胸管留置2天。
- 单孔机器人组较传统机器人和视频辅助手术组手术时间更短、出血更少。
核心结论
- 达芬奇单孔机器人胸腔镜用于解剖性肺切除安全可行。
- 需更大规模对照研究验证其有效性及与其他平台的优势比较。
研究设计与样本
- 同时获取另一临床试验(RVlob Trial: NCT03134534)临床数据进行比较。
主要发现
- 15例手术均成功,无术中中转,3例因高BMI和解剖复杂需加辅助孔。
- 中位术中出血15(IQR 10-37.5)mL,中位手术时间100(IQR 86-119)分钟。
- 中位住院时间8(IQR 7-9)天,中位胸管留置2(IQR 2-2)天,无再住院或再入院。
- 与传统机器人辅助和视频辅助手术组比较,单孔机器人组手术时间更短、出血更少。
临床怎么用
- 可考虑将达芬奇单孔机器人系统用于适合微创解剖性肺切除的高度恶性肺结节患者。
- 高BMI或解剖复杂患者需准备辅助孔以确保手术安全。
局限性
- 样本量仅15例,为非对照前瞻性真实世界研究。
- 与另一试验数据比较非随机对照,证据级别有限。
- 需更大规模对照研究验证有效性及平台间优势比较。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Robotic systems have enhanced thoracic surgery through 3D visualization, manoeuvrability, and tremor filtration. This study evaluated the effectiveness and safety of the da Vinci single-port surgical system for thoracic surgery in a Chinese population (ClinicalTrials.gov; NCT06246617). DESIGN: Patients with highly malignant pulmonary nodules suitable for minimally invasive lung resection underwent anatomical lung resection using a single-port robotic system between December 2023 and May 2024. Perioperative and short-term follow-up outcomes were also assessed. Clinical data from another clinical trial (RVlob Trial: NCT03134534) were also obtained for comparison. RESULTS: The procedure was successful in all 15 patients without intraoperative conversion, although 3 required an additional auxiliary port owing to a high body mass index and complex anatomy. Additionally, the median intraoperative blood loss and operative time were 15 (interquartile range [IQR], 10-37.5) mL and 100 (IQR, 86-119) minutes, respectively. The median length of hospital stay and duration of thoracic catheter retention were 8 (IQR, 7-9) and 2 (IQR, 2-2) days, respectively. No rehospitalizations or readmissions occurred. In comparison to the traditional robotic-assisted and video-assisted surgery groups, the single-port robotic surgery group showed a shorter operative time and less blood loss. CONCLUSIONS: Single-port robotic thoracic surgery using the da Vinci single-port surgical system is safe and feasible for anatomical lung resection. Moreover, larger controlled studies are required to validate its effectiveness and compare its advantages with those of other surgical platforms. CLINICAL TRIAL REGISTRATION NUMBER: ClinicalTrials.gov; NCT06246617.
引用
- Li C, Chen X, Wang X, et al. Single-Port Robotic-Assisted Approach in Thoracic Surgery: A Prospective Real-World Study. Interdiscip Cardiovasc Thorac Surg. 2025. PMID: 40658465. doi:10.1093/icvts/ivaf161
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。